These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 9576745)
1. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. Mizuno S; Kurosawa T; Matsumoto K; Mizuno-Horikawa Y; Okamoto M; Nakamura T J Clin Invest; 1998 May; 101(9):1827-34. PubMed ID: 9576745 [TBL] [Abstract][Full Text] [Related]
2. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy. Mizuno S; Nakamura T Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594 [TBL] [Abstract][Full Text] [Related]
3. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice. Yang J; Dai C; Liu Y Gene Ther; 2001 Oct; 8(19):1470-9. PubMed ID: 11593360 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES. Gong R; Rifai A; Tolbert EM; Biswas P; Centracchio JN; Dworkin LD J Am Soc Nephrol; 2004 Nov; 15(11):2868-81. PubMed ID: 15504940 [TBL] [Abstract][Full Text] [Related]
5. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Yang J; Liu Y Am J Physiol Renal Physiol; 2003 Feb; 284(2):F349-57. PubMed ID: 12529273 [TBL] [Abstract][Full Text] [Related]
7. Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice. Mizuno S; Matsumoto K; Kurosawa T; Mizuno-Horikawa Y; Nakamura T Kidney Int; 2000 Mar; 57(3):937-48. PubMed ID: 10720947 [TBL] [Abstract][Full Text] [Related]
8. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. Dai C; Yang J; Bastacky S; Xia J; Li Y; Liu Y J Am Soc Nephrol; 2004 Oct; 15(10):2637-47. PubMed ID: 15466268 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Mizuno S; Matsumoto K; Nakamura T Kidney Int; 2001 Apr; 59(4):1304-14. PubMed ID: 11260391 [TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. Liu Y Am J Physiol Renal Physiol; 2004 Jul; 287(1):F7-16. PubMed ID: 15180923 [TBL] [Abstract][Full Text] [Related]
11. [Molecular basis for HGF-mediated regression of renal fibrosis]. Mizuno S; Nakamura T Nihon Rinsho; 2006 Feb; 64 Suppl 2():312-21. PubMed ID: 16523909 [No Abstract] [Full Text] [Related]
12. Diffuse glomerulosclerosis without tubular injury does not directly manifest renal dysfunction in nephrotic mice (ICGN strain). Mizuno S; Yue BF; Okamoto M; Horikawa Y; Kurosawa T Exp Nephrol; 1997; 5(6):498-507. PubMed ID: 9438179 [TBL] [Abstract][Full Text] [Related]
13. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents. Negri AL J Nephrol; 2004; 17(4):496-503. PubMed ID: 15372410 [TBL] [Abstract][Full Text] [Related]
14. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy. Yamaura K; Ito K; Tsukioka K; Wada Y; Makiuchi A; Sakaguchi M; Akashima T; Fujimori M; Sawa Y; Morishita R; Matsumoto K; Nakamura T; Suzuki J; Amano J; Isobe M Circulation; 2004 Sep; 110(12):1650-7. PubMed ID: 15364799 [TBL] [Abstract][Full Text] [Related]
15. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. Yang J; Dai C; Liu Y J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870 [TBL] [Abstract][Full Text] [Related]
16. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation. Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933 [TBL] [Abstract][Full Text] [Related]
17. Direct transfer of hepatocyte growth factor gene into kidney suppresses cyclosporin A nephrotoxicity in rats. Yazawa K; Isaka Y; Takahara S; Imai E; Ichimaru N; Shi Y; Namba Y; Okuyama A Nephrol Dial Transplant; 2004 Apr; 19(4):812-6. PubMed ID: 15031334 [TBL] [Abstract][Full Text] [Related]
18. [Expression of TGF-beta and hepatocyte growth factor in kidney tissues of children with primary focal segmental glomerular sclerosis]. Wei MJ; Wu WL; Chen MY Zhongguo Dang Dai Er Ke Za Zhi; 2010 Aug; 12(8):630-3. PubMed ID: 20704796 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic targets for prevention and regression of progressive fibrosing renal diseases. Eitner F; Floege J Curr Opin Investig Drugs; 2005 Mar; 6(3):255-61. PubMed ID: 15816501 [TBL] [Abstract][Full Text] [Related]
20. Increase urinary hepatocyte growth factor excretion in human acute renal failure. Taman M; Liu Y; Tolbert E; Dworkin LD Clin Nephrol; 1997 Oct; 48(4):241-5. PubMed ID: 9352159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]